Market forecast:
Stock Market Today read more
Stock Market this Week read more
Below my transactions (older than 1 month) from group G: info
Target reached and tapped.
ETF provider: SPDR (State Street Global Advisers)
Ticker: XPH
ISIN: US78464A7220
Currency: Dollar
Exchange: Nyse Arca
On May 9 still able to sell 5% profit within three days. Now with a decline but again got on again.
ETF provider: iShares (BlackRock)
Ticker: IBB
ISIN: US4642875565
Exchange: Nasdaq
It runs still not comfortable with biotech. The low interest rates, I expect still a number of acquisitions. The price is close to the bottom.
Ticker: XRT
ISIN: US78464A7147
Exchange: NYSE Arca
Still just a drop after my last purchase. Low interest rates and almost everyone has a job, then it may not be long before going to restore a retail ETF.
Significant drop despite overall the figures listed companies accounted for the first quarter. But investors apparently had expected more. This sector is very healthy and low interest rates acquisitions are likely. So I just purchased on this dip.
The biotech sector is quite speculative. Looks like we are now well near a bottom. The low interest rates continue to acquisitions, and therefore higher prices very possible.
Despite the growth in the US in the juniors there is still growth and the economy is reasonably healthy. This retail ETF must have on consumer spending. With years go consumer spending increasing rather than decreasing falling unemployment and almost everyone at work and therefore even win wage increases.
With an increasingly aging population turnover increases can not be avoided. The pills sit in the corner where the blows fall because a few acquisitions were not allowed to continue. But with the extremely low interest rates, it will not be long before the takeover ghost will reappear with obviously higher prices.
ETF provider: Vanguard
Ticker: VGT
ISIN: US92204A7028
Obviously a sector that will continue to thrive. Even boarding a dip in the share price.